BioMarin Pharmaceuticals
BMRN
BMRN
528 hedge funds and large institutions have $14.7B invested in BioMarin Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 185 increasing their positions, 180 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
1.41% less ownership
Funds ownership: 98.11% → 96.7% (-1.4%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
38% less call options, than puts
Call options by funds: $107M | Put options by funds: $173M
Holders
528
Holding in Top 10
4
Calls
$107M
Puts
$173M
Top Buyers
| 1 | +$178M | |
| 2 | +$72.9M | |
| 3 | +$29.6M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$25.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$18.4M |
Top Sellers
| 1 | -$82.4M | |
| 2 | -$82.3M | |
| 3 | -$53.4M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$44M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$34.9M |